More than 50% of HIV diagnoses now occur in 48 counties in the United States. Cuyahoga County, home to Cleveland, is one of ...
LoveBScott on MSN
MISTR & SISTR Launch First-Ever National PrEP Day: A Bold Move to End HIV in the U.S.
Oct. 10, 2025, is officially the first-ever National PrEP Day, and MISTR and SISTR are going big. Their goal? Get 10,000 new ...
A long-acting HIV jab promises near-perfect protection at just $40 a year, but 115 nations must wait for India's approval of ...
Gilead Sciences, Inc. (NASDAQ:GILD) is one of the Most Undervalued Growth Stocks to Buy According to Hedge Funds. On September 21, Terence Flynn from Morgan Stanley maintained a Buy rating on Gilead ...
The CDC made a strong recommendation based on a high certainty of evidence to use the long-acting injectable lenacapavir ...
UK must step up to support global multilateral efforts to tackle disease The Global Fund to Fight AIDS, Tuberculosis, and Malaria was established in 2002 as an international financing mechanism and ...
OKLAHOMA CITY, Sept. 11, 2025 /PRNewswire/ -- Equality Health is increasing its efforts to prevent HIV by increasing the availability of PrEP (pre-exposure prophylaxis) throughout Oklahoma. This ...
An X-ray crystal structure of MK-8527 triphosphate (TP) bound to the complex of HIV reverse transcriptase and DNA shows the drug candidate’s alkyne extending into a key pocket to the upper left of the ...
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced a partnership with the U.S. State Department and the United States President’s Emergency Plan for AIDS Relief ...
Introduction: Title X-funded family planning clinics stand to play a significant role in Ending the HIV Epidemic (EHE), as a unique access point for cisgender women in the U.S. who account for ...
Meeting UNAIDS’ “95/95/95” targets for 2025—95% of people with HIV knowing their status, 95% of those who know their status on treatment, and 95% of people on treatment having a suppressed viral ...
A new pre-exposure prophylaxis (PrEP) drug has shown promise as a once-monthly oral pill to help prevent HIV. PrEP plays a key part in reducing the number of new HIV infections by stopping the virus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results